HEALTHSTORY 549· AUGUST 10, 2026

Sanofi Pompe disease drug shortage hits Myozyme and Nexviazyme as FDA flags Waterford plant

Two medicines used to treat Pompe disease, a rare inherited muscle disorder caused by the abnormal buildup of glycogen in the body's cells, are running short across the United States and Europe. Sanofi, which manufactures both drugs, has…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 548NIH moves to cut visa-holding researchers from a key early-career grant NEXT STORY 550 →Oil rises as traders weigh mixed signals on a possible U.S.-Iran Strait of Hormuz deal

Keep reading

More from the desk.

21HEALTH

Sanfilippo syndrome gets its first gene therapy approval after more than a decade of research

A rare childhood disease called Sanfilippo syndrome now has an approved gene therapy, the first one in the disease's history. Gene therapy, in plain terms, is a treatment that introduces corrected genetic material into a patient's cells to…

health1 MIN

33HEALTH

A rare genetic variant raises lung cancer risk 25-fold in people who have never smoked

Researchers have identified a rare genetic variant tied to a 25-fold increase in lung cancer odds among people who have never smoked, according to a study published Thursday in the journal Science. A genetic variant is a small, inherited…

health2 MIN

62HEALTH

Pennsylvania records fourth measles death, an 18-year-old from Mifflin County

Pennsylvania has now reported a fourth death connected to measles. The latest was an 18-year-old resident of Mifflin County, in the center of the state, who died from acute disseminated encephalomyelitis, a rare and severe neurological…

health1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk